Correlation Between Utah Medical and Bionano Genomics

Can any of the company-specific risk be diversified away by investing in both Utah Medical and Bionano Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Utah Medical and Bionano Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Utah Medical Products and Bionano Genomics, you can compare the effects of market volatilities on Utah Medical and Bionano Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Utah Medical with a short position of Bionano Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Utah Medical and Bionano Genomics.

Diversification Opportunities for Utah Medical and Bionano Genomics

0.59

Correlation Coefficient

Utah Medical  Bionano Genomics

Very weak diversification

The 3 months correlation between Utah and Bionano is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Utah Medical Products and Bionano Genomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionano Genomics and Utah Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Utah Medical Products are associated (or correlated) with Bionano Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionano Genomics has no effect on the direction of Utah Medical i.e., Utah Medical and Bionano Genomics go up and down completely randomly.

Pair Corralation between Utah Medical and Bionano Genomics

Given the investment horizon of 90 days Utah Medical Products is expected to generate 0.12 times more return on investment than Bionano Genomics. However, Utah Medical Products is 8.51 times less risky than Bionano Genomics. It trades about -0.12 of its potential returns per unit of risk. Bionano Genomics is currently generating about -0.34 per unit of risk. If you would invest  6,058  in Utah Medical Products on December 28, 2024 and sell it today you would lose (386.00) from holding Utah Medical Products or give up 6.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Utah Medical Products  vs.  Bionano Genomics

Utah Medical Products

Risk-Adjusted Performance

Very Weak

Over the last 90 days Utah Medical Products has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Bionano Genomics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bionano Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Utah Medical and Bionano Genomics

The main advantage of trading using opposite Utah Medical and Bionano Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Utah Medical position performs unexpectedly, Bionano Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will offset losses from the drop in Bionano Genomics' long position.

The idea behind Utah Medical Products and Bionano Genomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.